VXRT:OTCMKTS
Vaxart Inc
US$0.44
arrow_upward
+1.27%(+0.0055) 1 天
10月12日, GMT-4 16:00:00 · USD
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 VXRT 生成关键数据洞见…
开盘价
US$0.43
最高价
US$0.47
最低价
US$0.43
市值
1.08亿
平均成交量
25.33万
成交量
34.99万
市盈率
2.70
52 周最高价
US$0.84
52 周最低价
US$0.30
每股收益
US$0.16
Beta 版
1.05
流通股数
2.43亿
员工人数
65
开盘价
US$0.43
最高价
US$0.47
最低价
US$0.43
市值
1.08亿
平均成交量
25.33万
成交量
34.99万
市盈率
2.70
52 周最高价
US$0.84
52 周最低价
US$0.30
每股收益
US$0.16
Beta 版
1.05
流通股数
2.43亿
员工人数
65
新闻报道
来自网络来源和新闻合作伙伴
TradingKey
·
20小时前
道指升近200点，费半跌超2%；记忆体股跌幅居前；美光跌逾4%，Meta升超3%
www.tmgm.com
·
5小时前
道琼斯工业平均指数小幅走高，因无存储芯片可供出售
FX168
·
2小时前
美股收评：道指三连涨，美光重挫近4%拖累纳指，财报与通胀考验将至
Traders Union
·
1天前
Ryan Detrick指出，S&P 500自2019年以来的涨幅主要由盈利和股息推动
资料
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in 2004, the company later changed its name to Vaxart, Inc. in July 2007, after reincorporating in Delaware. A significant development in the company's history was the reverse merger with Aviragen Therapeutics, Inc. on February 13, 2018, which led to Vaxart becoming a wholly owned subsidiary of Aviragen. Post-merger, the company continued as Vaxart, Inc.
Vaxart's development portfolio includes a range of oral vaccines targeting infectious diseases such as norovirus, COVID-19, and seasonal influenza, as well as therapeutic vaccines like those targeting HPV. Wikipedia
Vaxart Inc简介